In the described sequence for treating iron deficiency anemia, what is the final therapy?

In the described sequence for treating iron deficiency anemia, what is the final therapy?

• A. Oral iron for 3 months -> IV iron -> epoetin
• B. IV iron
• C. Blood transfusion
• D. Epoetin/darbepoetin

Answer: (D)

The key idea is that treating iron deficiency anemia starts by correcting iron stores, then addressing ongoing inadequate erythropoiesis if it persists. You begin with iron supplementation (oral or IV) to replenish iron more quickly and properly. If the patient’s anemia still remains after iron repletion, especially when the problem is insufficient erythropoietic drive (as seen with conditions like chronic kidney disease or other scenarios where endogenous EPO is low), you use an erythropoiesis-stimulating agent to boost red blood cell production. Epoetin or darbepoetin serves as the final step to stimulate the marrow to produce more RBCs once iron stores are adequately replenished. Blood transfusion is typically reserved for acute, severe anemia or life-threatening situations, not as the planned final step in a chronic treatment sequence.

The key idea is that treating iron deficiency anemia starts by correcting iron stores, then addressing ongoing inadequate erythropoiesis if it persists. You begin with iron supplementation (oral or IV) to replenish iron more quickly and properly. If the patient’s anemia still remains after iron repletion, especially when the problem is insufficient erythropoietic drive (as seen with conditions like chronic kidney disease or other scenarios where endogenous EPO is low), you use an erythropoiesis-stimulating agent to boost red blood cell production. Epoetin or darbepoetin serves as the final step to stimulate the marrow to produce more RBCs once iron stores are adequately replenished. Blood transfusion is typically reserved for acute, severe anemia or life-threatening situations, not as the planned final step in a chronic treatment sequence.